Lumicitabine

DB14808InvestigationalSmall molecule

Lumicitabine is under investigation in clinical trial NCT03010059 (A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to...

Chemical structure of Lumicitabine
Formula / weight
C18H25ClFN3O6 · 433.86 g/mol (avg)
Also known as
ALS-008176

Resolves to

Compound
UNIIBNW5PQ52G1CAS1445385-02-3ChEMBLCHEMBL3417258
Structure
InChIKeyMJVKYGMNSQJLIN-KYZVSKTDSA-NSMILESCC(C)C(=O)OC[C@@]1(CCl)O[C@H]([C@H](F)[C@@H]1OC(=O)C(C)C)N1C=CC(N)=NC1=O

What you can answer from here — as of April 23, 2025

11Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Lumicitabine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In